{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T20:53:05Z","timestamp":1771275185054,"version":"3.50.1"},"reference-count":73,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,15]],"date-time":"2024-12-15T00:00:00Z","timestamp":1734220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.revmed.2024.12.004","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T12:20:57Z","timestamp":1735302057000},"page":"220-228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Utilisation de l\u2019hydroxychloroquine dans les pathologies obst\u00e9tricales r\u00e9currentes \u00e0 m\u00e9diation immune (en dehors du lupus syst\u00e9mique)\u00a0: fondements et preuves scientifiques"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0829-8764","authenticated-orcid":false,"given":"Amandine","family":"Dernoncourt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9ry","family":"Salle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meryam","family":"Cheloufi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"Kayem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ars\u00e8ne","family":"Mekinian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2024.12.004_bib0365","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.molmed.2023.05.009","article-title":"Immunobiology of pregnancy: from basic science to translational medicine","volume":"29","author":"Colamatteo","year":"2023","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.revmed.2024.12.004_bib0370","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1038\/nm.3012","article-title":"Mechanisms of implantation: strategies for successful pregnancy","volume":"18","author":"Cha","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.revmed.2024.12.004_bib0375","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.3389\/fimmu.2020.02025","article-title":"T Helper (Th) cell profiles in pregnancy and recurrent pregnancy losses: Th1\/Th2\/Th9\/Th17\/Th22\/Tfh cells","volume":"11","author":"Wang","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.revmed.2024.12.004_bib0380","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.fertnstert.2020.10.031","article-title":"Successful implantation is associated with a transient increase in serum pro-inflammatory cytokine profile followed by a switch to anti-inflammatory cytokine profile prior to confirmation of pregnancy","volume":"115","author":"Zhao","year":"2021","journal-title":"Fertil Steril"},{"key":"10.1016\/j.revmed.2024.12.004_bib0385","doi-asserted-by":"crossref","first-page":"SI86","DOI":"10.1093\/rheumatology\/kead537","article-title":"Pregnancy in antiphospholipid syndrome: what should a rheumatologist know?","volume":"63","author":"Andreoli","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2024.12.004_bib0390","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41584-018-0032-6","article-title":"Obstetric and vascular antiphospholipid syndrome: same antibodies but different diseases?","volume":"14","author":"Meroni","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.revmed.2024.12.004_bib0395","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.3390\/ijms24021331","article-title":"Hydroxychloroquine as an immunomodulatory and antithrombotic treatment in antiphospholipid syndrome","volume":"24","author":"Arachchillage","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.revmed.2024.12.004_bib0400","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/annrheumdis-2019-215213","article-title":"EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"78","author":"Tektonidou","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2024.12.004_bib0405","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/bcp.14131","article-title":"Hydroxychloroquine may be beneficial in preeclampsia and recurrent miscarriage","volume":"86","author":"de\u00a0Moreuil","year":"2020","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.revmed.2024.12.004_bib0410","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3109\/08916934.2014.939267","article-title":"Chronic histiocytic intervillositis: outcome, associated diseases and treatment in a multicenter prospective study","volume":"48","author":"Mekinian","year":"2015","journal-title":"Autoimmunity"},{"key":"10.1016\/j.revmed.2024.12.004_bib0415","doi-asserted-by":"crossref","first-page":"945543","DOI":"10.3389\/fendo.2022.945543","article-title":"Chronic histiocytic intervillositis (CHI): current treatments and perinatal outcomes, a systematic review and a meta-analysis","volume":"13","author":"Moar","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.revmed.2024.12.004_bib0420","doi-asserted-by":"crossref","first-page":"753220","DOI":"10.3389\/fmed.2021.753220","article-title":"Immunomodulatory therapy reduces the severity of placental lesions in chronic histiocytic intervillositis","volume":"8","author":"Brady","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.revmed.2024.12.004_bib0425","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.placenta.2020.07.032","article-title":"Chronic Intervillositis of Unknown Etiology (CIUE): Prevalence, patterns and reproductive outcomes at a tertiary referral institution","volume":"100","author":"Simula","year":"2020","journal-title":"Placenta"},{"key":"10.1016\/j.revmed.2024.12.004_bib0430","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1093\/humrep\/deae146","article-title":"Hydroxychloroquine in recurrent pregnancy loss: data from a French prospective multicenter registry","volume":"39","author":"Dernoncourt","year":"2024","journal-title":"Hum Reprod"},{"key":"10.1016\/j.revmed.2024.12.004_bib0435","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1186\/s13063-020-04716-1","volume":"21","author":"Yang","year":"2020","journal-title":"Trials"},{"key":"10.1016\/j.revmed.2024.12.004_bib0440","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/humupd\/dmm011","article-title":"The role of the endometrium and embryo in human implantation","volume":"13","author":"Diedrich","year":"2007","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.revmed.2024.12.004_bib0445","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.fertnstert.2019.02.009","article-title":"What exactly is endometrial receptivity?","volume":"111","author":"Lessey","year":"2019","journal-title":"Fertil Steril"},{"key":"10.1016\/j.revmed.2024.12.004_bib0450","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1093\/humupd\/dmaa062","article-title":"Uterine natural killer cells: from foe to friend in reproduction","volume":"27","author":"D\u00edaz-Hern\u00e1ndez","year":"2021","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.revmed.2024.12.004_bib0455","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.thromres.2004.06.038","article-title":"Growth and function of the normal human placenta","volume":"114","author":"Gude","year":"2004","journal-title":"Thromb Res"},{"key":"10.1016\/j.revmed.2024.12.004_bib0460","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aat6114","article-title":"Immune responses at the maternal-fetal interface","volume":"4","author":"Ander","year":"2019","journal-title":"Sci Immunol"},{"key":"10.1016\/j.revmed.2024.12.004_bib0465","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41584-020-0372-x","article-title":"Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology","volume":"16","author":"Schrezenmeier","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.revmed.2024.12.004_bib0470","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X211073001","article-title":"Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge","volume":"14","author":"Dima","year":"2022","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.revmed.2024.12.004_bib0475","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1136\/annrheumdis-2016-210012","article-title":"Hydroxychloroquine inhibits proinflammatory signalling pathways by targeting endosomal NADPH oxidase","volume":"76","author":"M\u00fcller-Calleja","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2024.12.004_bib0480","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.4049\/jimmunol.1400571","article-title":"Identification of activators of ERK5\u00a0transcriptional activity by high-throughput screening and the role of endothelial ERK5\u00a0in vasoprotective effects induced by statins and antimalarial agents","volume":"193","author":"Le","year":"2014","journal-title":"J Immunol Baltim"},{"key":"10.1016\/j.revmed.2024.12.004_bib0485","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1161\/CIRCRESAHA.107.156877","article-title":"Extracellular signal-regulated kinase 5\u00a0SUMOylation antagonizes shear stress-induced antiinflammatory response and endothelial nitric oxide synthase expression in endothelial cells","volume":"102","author":"Woo","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.revmed.2024.12.004_bib0490","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/art.41621","article-title":"Higher hydroxychloroquine blood levels are associated with reduced thrombosis risk in systemic lupus erythematosus","volume":"73","author":"Petri","year":"2021","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"10.1016\/j.revmed.2024.12.004_bib0495","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/art.27289","article-title":"The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus","volume":"62","author":"Jung","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2024.12.004_bib0500","doi-asserted-by":"crossref","first-page":"e001223","DOI":"10.1136\/lupus-2024-001223","article-title":"Antiplatelet effects of hydroxychloroquine in patients with systemic lupus erythematosus evaluated by the total thrombus-formation analysis system (T-TAS)","volume":"11","author":"Hiraoka","year":"2024","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.revmed.2024.12.004_bib0505","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/art.10150","article-title":"Evidence of transplacental passage of hydroxychloroquine in humans","volume":"46","author":"Costedoat-Chalumeau","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2024.12.004_bib0510","doi-asserted-by":"crossref","first-page":"290.e1","DOI":"10.1016\/j.ajog.2020.09.007","article-title":"Hydroxychloroquine early in pregnancy and risk of birth defects","volume":"224","author":"Huybrechts","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.revmed.2024.12.004_bib0515","doi-asserted-by":"crossref","first-page":"e000651","DOI":"10.1136\/lupus-2021-000651","article-title":"Hydroxychloroquine in the pregnancies of women with lupus: a meta-analysis of individual participant data","volume":"9","author":"Clowse","year":"2022","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.revmed.2024.12.004_bib0520","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1093\/rheumatology\/keaa592","article-title":"Fetal safety of chloroquine and hydroxychloroquine use during pregnancy: a nationwide cohort study","volume":"60","author":"Andersson","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2024.12.004_bib0525","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/art.42015","article-title":"Birth outcomes in women who have taken hydroxycholoroquine during pregnancy: a prospective cohort study","volume":"74","author":"Chambers","year":"2022","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"10.1016\/j.revmed.2024.12.004_bib0530","article-title":"Hydroxychloroquine in lupus or rheumatoid arthritis pregnancy and risk of major congenital malformations: a population-based cohort study","author":"Nguyen","year":"2024","journal-title":"Rheumatology"},{"key":"10.1016\/j.revmed.2024.12.004_bib0535","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/art.42624","article-title":"The 2023\u00a0ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"75","author":"Barbhaiya","year":"2023","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"10.1016\/j.revmed.2024.12.004_bib0540","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jaut.2016.04.008","article-title":"Complement inhibition by hydroxychloroquine prevents placental and fetal brain abnormalities in antiphospholipid syndrome","volume":"75","author":"Bertolaccini","year":"2016","journal-title":"J Autoimmun"},{"key":"10.1016\/j.revmed.2024.12.004_bib0545","doi-asserted-by":"crossref","first-page":"6157","DOI":"10.1080\/14767058.2021.1908992","article-title":"Hydroxychloroquine in obstetric antiphospholipid syndrome: rationale and results of an observational study of refractory cases","volume":"35","author":"Khizroeva","year":"2022","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.revmed.2024.12.004_bib0550","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.thromres.2021.08.004","article-title":"The impact of hydroxychloroquine on obstetric outcomes in refractory obstetric antiphospholipid syndrome","volume":"206","author":"Gerde","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/j.revmed.2024.12.004_bib0555","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.autrev.2015.01.012","article-title":"The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: Data from a European multicenter retrospective study","volume":"14","author":"Mekinian","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.revmed.2024.12.004_bib0560","first-page":"639","article-title":"Effect of additional treatments combined with conventional therapies in pregnant patients with high-risk antiphospholipid syndrome: a multicentre study","volume":"118","author":"Ruffatti","year":"2018","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.revmed.2024.12.004_bib0565","doi-asserted-by":"crossref","first-page":"576.e7","DOI":"10.1016\/j.ajog.2011.06.064","article-title":"Hydroxychloroquine reduces binding of antiphospholipid antibodies to syncytiotrophoblasts and restores annexin A5\u00a0expression","volume":"205","author":"Wu","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.revmed.2024.12.004_bib0570","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1111\/jcmm.17459","article-title":"Protection by hydroxychloroquine prevents placental injury in obstetric antiphospholipid syndrome","volume":"26","author":"Liu","year":"2022","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.revmed.2024.12.004_bib0575","first-page":"598","article-title":"[Hydroxychloroquine to obtain pregnancy without adverse obstetrical events in primary antiphospholipid syndrome: French phase II multicenter randomized trial, HYDROSAPL]","volume":"46","author":"Mekinian","year":"2018","journal-title":"Gynecol Obstet Fertil Senol"},{"key":"10.1016\/j.revmed.2024.12.004_bib0580","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.autrev.2018.05.012","article-title":"HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome","volume":"17","author":"Belizna","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.revmed.2024.12.004_bib0585","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1055\/s-0037-1603359","volume":"43","author":"Schreiber","year":"2017","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.revmed.2024.12.004_bib716","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejogrb.2016.02.015","article-title":"Pregnancy loss: French clinical practice guidelines","volume":"201","author":"Huchon","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.revmed.2024.12.004_bib0590","first-page":"hoad002","article-title":"ESHRE guideline: recurrent pregnancy loss: an update in 2022","volume":"2023","author":"Bender Atik","year":"2023","journal-title":"Hum Reprod Open"},{"key":"10.1016\/j.revmed.2024.12.004_bib0595","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0140-6736(21)00682-6","article-title":"Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss","volume":"397","author":"Quenby","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2024.12.004_bib0600","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41572-020-00228-z","article-title":"Recurrent pregnancy loss","volume":"6","author":"Dimitriadis","year":"2020","journal-title":"Nat Rev Dis Primer"},{"key":"10.1016\/j.revmed.2024.12.004_bib0605","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/AOG.0b013e31823c0413","article-title":"Prognosis for live birth in women with recurrent miscarriage: what is the best measure of success?","volume":"119","author":"Lund","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.revmed.2024.12.004_bib0610","doi-asserted-by":"crossref","first-page":"l869","DOI":"10.1136\/bmj.l869","article-title":"Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study","volume":"364","author":"Magnus","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.revmed.2024.12.004_bib0615","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.fertnstert.2013.11.004","article-title":"The nature of aneuploidy with increasing age of the female partner: a review of 15,169\u00a0consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening","volume":"101","author":"Franasiak","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.revmed.2024.12.004_bib0620","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0015-0282(99)00495-1","article-title":"Embryonic karyotype of abortuses in relation to the number of previous miscarriages","volume":"73","author":"Ogasawara","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.revmed.2024.12.004_bib0625","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s10815-022-02414-2","article-title":"Recurrent pregnancy loss: fewer chromosomal abnormalities in products of conception? A meta-analysis","volume":"39","author":"Lei","year":"2022","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.revmed.2024.12.004_bib0630","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1080\/01443615.2022.2141615","article-title":"The effect of hydroxychloroquine on pregnancy outcomes in patients with unexplained recurrent pregnancy loss: a placebo-controlled study \u201cpilot study\u201d","volume":"42","author":"Moini","year":"2022","journal-title":"J Obstet Gynaecol J Inst Obstet Gynaecol"},{"key":"10.1016\/j.revmed.2024.12.004_bib0635","doi-asserted-by":"crossref","first-page":"e025649","DOI":"10.1136\/bmjopen-2018-025649","article-title":"Hydroxychloroquine for prevention of recurrent miscarriage: study protocol for a multicentre randomised placebo-controlled trial BBQ study","volume":"9","author":"Pasquier","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.revmed.2024.12.004_bib0640","article-title":"Quel bilan proposer apr\u00e8s une grossesse compliqu\u00e9e de pathologie vasculo-placentaire\u00a0? [Which workup should be performed after a pregnancy complicated with vasculo-placental disorder?]","author":"de Moreuil","year":"2024","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2024.12.004_bib0645","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.placenta.2016.04.017","article-title":"Perinatal prognosis of pregnancies complicated by placental chronic villitis or intervillositis of unknown etiology and combined lesions: About a series of 178\u00a0cases","volume":"44","author":"Nowak","year":"2016","journal-title":"Placenta"},{"key":"10.1016\/j.revmed.2024.12.004_bib0650","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s00404-014-3536-6","article-title":"Antiphospholipid syndrome and other autoimmune diseases associated with chronic intervillositis","volume":"291","author":"Revaux","year":"2015","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.revmed.2024.12.004_bib0655","doi-asserted-by":"crossref","first-page":"12611","DOI":"10.1038\/s41598-020-69191-9","article-title":"Adverse perinatal outcomes of chronic intervillositis of unknown etiology: an observational retrospective study of 122\u00a0cases","volume":"10","author":"Mattuizzi","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.revmed.2024.12.004_bib0660","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.revmed.2017.10.422","article-title":"Intervillites chroniques histiocytaires\u00a0: bilan et prise en charge","volume":"39","author":"Mekinian","year":"2018","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2024.12.004_bib0665","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.jacc.2020.08.014","article-title":"Preeclampsia\u2014Pathophysiology and clinical presentations: JACC State-of-the-Art Review","volume":"76","author":"Ives","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.revmed.2024.12.004_bib0670","doi-asserted-by":"crossref","first-page":"S954","DOI":"10.1016\/j.ajog.2020.10.024","article-title":"The placenta and preeclampsia: villain or victim?","volume":"226","author":"Melchiorre","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.revmed.2024.12.004_bib0675","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41581-022-00670-0","article-title":"The role of immune cells and mediators in preeclampsia","volume":"19","author":"Deer","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.revmed.2024.12.004_bib0680","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ajog.2006.06.044","article-title":"Outcomes of subsequent pregnancy after first pregnancy with early-onset preeclampsia","volume":"195","author":"van\u00a0Rijn","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.revmed.2024.12.004_bib0685","doi-asserted-by":"crossref","first-page":"e000681","DOI":"10.1136\/lupus-2022-000681","article-title":"Influence of hydroxychloroquine blood levels on adhesion molecules associated with endothelial dysfunction in patients with systemic lupus erythematosus","volume":"9","author":"Fasano","year":"2022","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.revmed.2024.12.004_bib0690","first-page":"330","article-title":"Chronic hydroxychloroquine improves endothelial dysfunction and protects kidney in a mouse model of systemic lupus erythematosus","volume":"64","author":"G\u00f3mez-Guzm\u00e1n","year":"2014","journal-title":"Hypertens Dallas Tex 1979"},{"key":"10.1016\/j.revmed.2024.12.004_bib0695","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s13075-015-0790-3","article-title":"Early treatment with hydroxychloroquine prevents the development of endothelial dysfunction in a murine model of systemic lupus erythematosus","volume":"17","author":"Virdis","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.revmed.2024.12.004_bib0700","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.3899\/jrheum.161351","article-title":"Longterm hydroxychloroquine therapy and low-dose aspirin may have an additive effectiveness in the primary prevention of cardiovascular events in patients with systemic lupus erythematosus","volume":"44","author":"Fasano","year":"2017","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2024.12.004_bib0705","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1042\/CS20080196","article-title":"Role of TNF-alpha in vascular dysfunction","volume":"116","author":"Zhang","year":"2009","journal-title":"Clin Sci Lond Engl"},{"key":"10.1016\/j.revmed.2024.12.004_bib0710","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1097\/HJH.0000000000003279","article-title":"Hydroxychloroquine reduces hypertension and soluble fms-like kinase-1\u00a0in a N\u03c9-nitro-l-arginine methyl ester-induced preeclampsia rat model","volume":"40","author":"Choi","year":"2022","journal-title":"J Hypertens"},{"key":"10.1016\/j.revmed.2024.12.004_bib0715","doi-asserted-by":"crossref","first-page":"e0271560","DOI":"10.1371\/journal.pone.0271560","article-title":"Hydroxychloroquine reduces soluble Flt-1\u00a0secretion from human cytotrophoblast, but does not mitigate markers of endothelial dysfunction in vitro","volume":"17","author":"Kadife","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.revmed.2024.12.004_bib0360","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.3390\/ijms21072504","article-title":"Hydroxychloroquine mitigates the production of 8-isoprostane and improves vascular dysfunction: implications for treating preeclampsia","volume":"21","author":"Rahman","year":"2020","journal-title":"Int J Mol Sci"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866324013420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866324013420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T11:54:38Z","timestamp":1744718078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866324013420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":73,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0248866324013420"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2024.12.004","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utilisation de l\u2019hydroxychloroquine dans les pathologies obst\u00e9tricales r\u00e9currentes \u00e0 m\u00e9diation immune (en dehors du lupus syst\u00e9mique)\u00a0: fondements et preuves scientifiques","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2024.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI).","name":"copyright","label":"Copyright"}]}}